NCT02872207View on ClinicalTrials.gov

Evaluation of the Stinging Potential in Human Eyes

NACompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

February 21, 2015

Primary Completion Date

February 22, 2015

Study Completion Date

February 22, 2015

Conditions

Sunscreen Agents

Interventions

DRUG

BAY 987516 (Y65-122)

5 µL in one eye

DRUG

BAY 987516 (Y65-118)

5 µL in one eye

DRUG

Control

5 uL in other eye

Trial Locations (1)

33714

St. Petersburg

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY

NCT02872207 - Evaluation of the Stinging Potential in Human Eyes | Biotech Hunter | Biotech Hunter